Global DNA Sequencing Market Report, published by Variant Market Research, forecast that the global market is expected to reach $26.1 Billion by 2025 from $6.6 Billion in 2017, growing at a CAGR of 18.7% from 2017 to 2025. By Geography, Asia-Pacific and Europe are expected to grow at a CAGR of 19.8% and 18.8%, respectively, during the forecast period.
“DNA Sequencing Market (By product: consumable, service, and instrument; Application: biomarkers and cancer, personalized medicine, reproductive health, diagnostics, forensics, and other applications: By Technology: sequencing by ligation, single molecule real time sequencing, chain termination sequencing, sequencing by synthesis, pyrosequencing, ion semiconductor sequencing, and nanopore sequencing; By End user: pharmaceutical companies, academic & government research institutes, biotechnology companies, and hospitals & clinics.; By Geography: North America, Europe, Asia-Pacific and Row) Global Scenario, Market Size, Outlook, Trend and Forecast, 2016 – 2025”
The global DNA Sequencing Market is mainly driven by rising incidences of cancer
The factor driving the growth of the global DNA sequencing market are increasing trends of personalized genomics, and technological advancements in new generation sequencing procedures. In addition, inherited rare disorders, and pre and neo-natal disorders, and rising incidences of cancer have also encouraged the growth of the market. However, increasing difficulty of diseases and high development and research expenses are the restraints of the market growth. Furthermore, personalized treatments and medicines, and non-invasive detection would provide lucrative opportunities to the market during the forecast period.
Product, application, technology, end user and geography are the bifurcations of the DNA sequencing market. By product, the market is classified into consumable, service, and instrument. Application segment includes biomarkers and cancer, personalized medicine, reproductive health, diagnostics, forensics, and other applications. Technology segment comprises sequencing by ligation, single molecule real time sequencing, chain termination sequencing, sequencing by synthesis, pyrosequencing, ion semiconductor sequencing, and nanopore sequencing. End user segment is categorized into pharmaceutical companies, academic & government research institutes, biotechnology companies, and hospitals & clinics.
The country wise analysis has been also covered under the scope of the report. North America covers the U.S., Canada, and Mexico. UK, Italy, Spain, Germany, France, and Rest of Europe are analyzed under the European market. China, Japan, India, South Korea, Taiwan, Australia, and Rest of Asia-Pacific are included under the Asia-Pacific market. While RoW is bifurcated into South America, Middle East, and Africa.
Consumables, by product segment led the market with major share in 2017
Consumables contributed for the majority of the share in 2017, in the product segment, and is expected to continue its trend during the forecast period. In terms of growth, owing to the sheer practice and necessity throughout the sample preparation, library construction, and other pre-requisite stages of DNA sequencing.
Biomarkers and cancer dominated the application segment in 2017
Biomarkers and cancer occupied the largest market share in the application segment and is likely to continue its dominance throughout the forecast period 2017 – 2025, due to rise in technological advancements in DNA sequencing, and rise in sequencing applications.
In technology segment, sequencing by synthesis lead the global market with maximum market share in 2017
Sequencing by synthesis, on the basis of technology segment accounted for the major market share in 2017 and would continue to maintain the trend over the forecast period, due to the widely-used DNA sequencing platforms utilize this technology in sequencing protocols.
North America accounted for the maximum share in the global DNA sequencing market
In 2017, North America was the highest revenue generating region of the global DNA sequencing market share. Likewise, Asia-Pacific is likely to achieve the fastest CAGR during the forecast period, owing to rise in DNA sequencing applications, and increase in awareness about DNA sequencing.
Prominent players operating in the market include Johnson & Johnson, Abbott Laboratories, ZS Genetics, GE Healthcare Life Sciences, Siemens AG, Eurofins Scientific, Macrogen, Inc., Oxford Nanopore Technologies, Bio-Rad Laboratories, Inc., and DNASTAR, Inc., among others.